Bria-TILsRx

N/A

Report date: 2025/06/11 11:17:49

Base Information

Drug NameBria-TILsRx
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody
Mechanisms of ActionT-cell receptor modulatorsImmunostimulantsT lymphocytes stimulants
TargetsT-cell receptor
Therapy Area/IndicationsProstatic NeoplasmsOvarian Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanada
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesBriacell Therapeutics Corp
China Registration ClassN/A

Develop Information

Active CompaniesBriacell Therapeutics Corp
Inactive CompaniesN/A
Active IndicationsProstatic NeoplasmsOvarian Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A